Understanding and Improving ¹⁸F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate Cancer

Figure 3

Image of an 81-year-old male who had received proton beam radiation therapy. He was referred for ¹⁸F-fluciclovine imaging with PSA rising to 3.3 ng/mL. This coronal, fused PET/CT view shows 3 prostate cancer metastases (white arrows). Note the node superiorly on the right, with very subtle ¹⁸F-fluciclovine uptake; this node is ∼3 mm.